LTP vs NEU

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

LTP

LTR PHARMA FPO [LTP]

49LOW

NEU

NEUREN FPO NZ [NEU]

47LOW

Score Breakdown

LTP NEU
Technical
68
61
Catalyst
53
50
Sentiment
50
50
Fundamental
50
62
Momentum
46
26
Risk Gate
46
43

Key Metrics

LTP Metric NEU
$89.1MMarket Cap$2.1B
386KAvg Volume (20d)725K
+0.1%Short Interest+4.9%
$0.81052-Week High$22.985
$0.28552-Week Low$11.000
-4.0%Daily Change+0.2%
$0.480Reference Price$16.530
-29.3%ROE+8.7%
N/AProfit Margin+47.1%

Active Signals

LTP Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 15.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet

NEU Signals

Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)
Piotroski F-Score strong (7/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
Earnings in sharp decline (-88% QoQ)

Ask Scout AI to compare LTP and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

LTP vs OCC →LTP vs ONE →LTP vs PKY →LTP vs TRI →MAP vs MVP →
LTP Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).